Populations of Focus

Adults with Preventive Care Needs Guide

Version 3 – June 2026

Putting the Key Activities in Context


Person-centered population-based care

Each of the key activities advance one or more of the seven person-centered population-based care change concepts:

  1. Operationalize clinical guidelines.
  2. Implement condition-specific registries.
  3. Proactive patient outreach and engagement.
  4. Pre-visit planning and care gap reduction.
  5. Care coordination.
  6. Behavioral health integration.
  7. Address social needs.

FIGURE 1: PHMI IMPLEMENTATION MODEL

PHMI Implementation Model

The measures covered in this guide consist of Healthcare Effective Data and Information Set (HEDIS) measures designated as core and supplemental measures by PHMI. These measures can be considered outcome measures because there is ample evidence that improved timely care will improve overall population health outcomes for adults requiring cancer screening. All measures use standard HEDIS definitions and are aligned with California Advancing and Innovating Medi-Cal (CalAIM) and Alternative Payment Methodology (APM) 2.0. For information about these measures, reference the PHMI Data Quality and Reporting Guide.

PHMI has selected one core and two supplemental measures of focus for adults with preventive care needs. Practices can track other measures that feel important and relevant. This guide provides detailed guidance to improve your practice’s results on the following four core and supplemental measures:

  1. Colorectal Cancer Screening (Core Measure).
  2. Breast Cancer Screening (Supplemental Measure).
  3. Cervical Cancer Screening (Supplemental Measure).

Core HEDIS measures for PHMI

PHMI Populations of Focus

Measures


Adults with preventive care needs

Colorectal Cancer Screening
Percentage of 45- to 75-year-old people who were screened for colorectal cancer at the recommended interval.

Supplemental HEDIS measures for PHMI

PHMI Populations of Focus

Measures


Adults with preventive care needs

Breast Cancer Screening
Percentage of people 50 to 74 years of age who had at least one mammogram to screen for breast cancer in the past two years.

Cervical Cancer Screening
Percentage of people who were screened for cervical cancer using any of the following criteria:

  • People 21 to 64 years of age who had cervical cytology performed within the last three years.
  • People 30 to 64 years of age who had cervical high-risk human papillomavirus (hrHPV) testing performed within the last five years.
  • People 30 to 64 years of age who had cervical cytology/high-risk human papillomavirus (hrHPV) cotesting within the last five years.

The core and supplemental measures are part of a larger measurement strategy and learning system, as outlined in Appendix A: Sample, Idealized System Diagram: Weaving Your Measurement Strategy and Learning System into Practice Operations. Key Activity 1: Convening a Multidisciplinary Implementation Team for Cancer Screening outlines how your practice can develop a robust measurement system to support this work. In addition to quality assurance and monitoring, measures are also used during practice operations alongside other data for learning to:

  • Guide the actions of the multidisciplinary implementation team as they use a systematic approach to decreasing inequities and implementing key activities across the practice.
  • Support the care team’s efforts to advance population health and reduce care gaps through daily, weekly and monthly workflows, as well as continuous identification of opportunities for improvement.

The PHMI Clinical Guidelines Advisory Group (CGAG) was established to create a standardized approach to review, adopt and promote established clinical guidelines in the PHMI cohort. For more information, please see the PHMI Clinical Practice Guidelines for Key Medi-Cal Populations of Focus.
Colorectal cancer screening clinical guidelines 

FIGURE 2: CLINICAL GUIDELINES: COLORECTAL CANCER SCREENING


Guideline source


PHMI measure

Colorectal Cancer Screening

Guideline language

Conduct colorectal cancer screening for persons aged 45 to 75 using any of the following screening modalities and intervals:

  • High-sensitivity guaiac-based fecal occult blood test (HsgFOBT) or fecal immunochemical test (FIT) every year.
  • Stool DNA (sDNA) FIT every one to three years.
  • Computed tomography (CT) colonography every five years.
  • Flexible sigmoidoscopy every five years.
  • Flexible sigmoidoscopy every 10 years and FIT every year.
  • Colonoscopy every 10 years.

Breast cancer screening clinical guidelines 

FIGURE 3: CLINICAL GUIDELINES: BREAST CANCER SCREENING


Guideline Source


PHMI Measure

Breast Cancer Screening

Guideline Language

Age to start Mammography (USPSTF): Biennial screening mammography is recommended for women aged 40 y/o. The decision to start screening mammography in women prior to age 40 y/o should be an individual one.
Age to stop Mammography (USPSTF): The current evidence is insufficient to assess the balance of benefits and harms of screening mammography in women aged 75 years or older.
Mammography Intervals (USPSTF): Biennial screening mammography is recommended for women aged 40 to 74 years.
Mammography for Transgender People (USPSTF): Transmasculine individuals are recommended to follow the guidelines for cisgender women.
High Risk Assessment (American College of Radiology/Society of Breast Imaging): Risk assessment by age 25 is recommended to determine if screening earlier than age 40 is needed.

Cervical cancer screening clinical guidelines 

FIGURE 4: CLINICAL GUIDELINES: CERVICAL CANCER SCREENING


Guideline Source


PHMI Measure

Cervical Cancer Screening

Guideline Language

Age 21-65 (USPSTF):

  • In women aged 21 to 29 years, screening for cervical cancer is recommended every 3 years with cervical cytology alone.
  • For women aged 30 to 65 years, screening every 3 years with cervical cytology alone, every 5 years with high-risk human papillomavirus (hrHPV) testing alone, or every 5 years with hrHPV testing in combination with cytology (cotesting) is recommended.

No Testing (USPSTF):

  • Recommends against screening for cervical cancer in women younger than 21 years
  • Recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion (ie, cervical intraepithelial neoplasia [CIN] grade 2 or 3) or cervical cancer.
  • Recommends against screening for cervical cancer in women older than 65 years who have had adequate prior screening and are not otherwise at high risk for cervical cancer.

Many key activities in this guide include considerations for utilizing the intervention to improve equitable health outcomes and reduce the effects of racism, bias and discrimination. Key Activity 4: Use a Systematic Approach to Address Inequities within the Population of Focus describes key action steps for how to make an intentional and explicit effort to identify inequities, understand root causes and reduce those inequities.

This guide also offers resources for going deeper into organizational and ecosystem-level work to advance equitable outcomes through Key Activity 16: Strengthen a Culture of Equity. More information about this approach can be found in the PHMI Equity Framework and Approach.

Integrated behavioral health supports are important for adults, as behavioral health support is likely to boost health outcomes and enhance patients' quality of life. One foundational change is to ensure that the care team includes behavioral health staff as core members of the team; this is covered in detail in the Care Teams and Workforce Guide.

To learn more about strategies for behavioral health integration see Getting Started with Behavioral Health Integration and the PHMI Behavioral Health Guide Key Activity 2: Enhance the Culture of Integrated Behavioral Healthcare and Key Activity 3: Enhance Operational Integration of Behavioral Health.

We also offer a resource, Pre-Visit Planning: Leveraging the Team to Identify and Address Gaps in Care, that includes recommended behavioral health screenings.

Throughout the key activities in this guide, we have incorporated considerations for providing trauma-informed care in the approach to cancer screening. Trauma is recognized as a potential barrier to seeking or engaging in cancer screening activities. Activities involved in breast, colon and cervical cancer screening may serve as potential triggers associated with the original trauma and should be considered and addressed carefully by clinicians. This guide, therefore, includes a resource for Trauma-Informed Population Health Management. For additional information about managing behavioral health conditions beyond screening, please see the behavioral health implementation guide.

For many key activities in this guide, we have highlighted considerations related to social needs at the individual or population level, such as expanding referral networks. Key Activity 8: Use Social Needs Screening to Inform Patient Treatment Plans can help practices better understand and support patient- and population-level needs. For Medi-Cal patients and families with high levels of social need, such as those experiencing homelessness, referrals to Enhanced Care Management (ECM) and Community Supports programs are available; see Key Activity 15: Provide Care Management for more.

For going deeper in this area, practices can see Key Activity 14: Continue to Develop Referral Relationships and Pathways for common social needs and Key Activity 13: Strengthen Community Partnerships to build upon the strengths, infrastructure and resources available in the community. More information about this dual patient- and population- level approach is available in the PHMI Social Health Framework and Approach.

Our theory of change is that if practices implement the activities contained in this guide, it will lead to improved health and well-being outcomes among the adults served by practices. See Appendix B: Theory of Change for a suggested driver diagram.